Methods to assess atherosclerotic cardiovascular risk in chronic respiratory diseases: a systematic review
Multiple ASCVD risk assessment methods exist for chronic respiratory diseases, highlighting the need to understand the strengths and weaknesses of tools for tailored solutions. Future studies should address validation, accessibility and improved personalised risk stratification.
Authors
- Ahmad M. Alharbi (ORCID: https://orcid.org/0000-0002-9512-1985)
- Siegfried K. Wagner (ORCID: https://orcid.org/0000-0003-4915-4353)
- John Robert Hurst (ORCID: https://orcid.org/0000-0002-7246-6040)
- Amar J. Shah (ORCID: https://orcid.org/0000-0002-7278-6909)
- Swapna Mandal (ORCID: https://orcid.org/0000-0002-2232-5880)
- Omer Faruk Uysal (ORCID: https://orcid.org/0009-0004-4201-0941)
- Jamie Brown (ORCID: https://orcid.org/0000-0002-2797-5428)
- Tobin Joseph (ORCID: https://orcid.org/0000-0002-9283-9895)
- Andrew P. Yu (ORCID: https://orcid.org/0009-0002-2161-5808)
- Chris P Gale
- Tanya Patrick
Institutions
- University of Leeds (GB)
- Royal Free London NHS Foundation Trust (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- NIHR Moorfields Biomedical Research Centre (GB)
- The London College (GB)
- University College London (GB)
Publication Details
- Journal
- European Respiratory Review
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1183/16000617.0050-2025
- Citations
- 1
- Primary Topic
- Cardiovascular Disease and Adiposity
- Type
- article
- Field-Weighted Citation Impact
- 1.39